Product patents
Griffin, J.
Lancet 338(8781): 1528
1991
ISSN/ISBN: 0140-6736 PMID: 1683951 Document Number: 379565
Document emailed within 1 workday
Related Documents
Martelliere, E. 1955: Special licenses concerning patents for the production of pharmaceuticals and the method of transferring patents Produits Pharmaceutiques 10(1): 50-52Mungiu, O.C.; Ionescu, G.D.; Antohie, C.; Dragomir, B.; Cotrutz, C. 1993: Pharmacotoxicological studies of a natural plant product in the PT series. I. the chronic toxicity of the product PT 2A Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 97(2): 323-327
Romano, J.W.; Van Damme, L.; Hillier, S. 2014: The future of multipurpose prevention technology product strategies: understanding the market in parallel with product development Bjog: An International Journal of Obstetrics and Gynaecology 121 Suppl. 5: 15-18
Van der Straten, A.; Moore, J.; Napierala, S.; Clouse, K.; Mauck, C.; Hammond, N.; Padian, N. 2008: Consistent use of a combination product versus a single product in a safety trial of the diaphragm and microbicide in Harare, Zimbabwe Contraception 77(6): 435-443
A.Zoom, A.A. 2002: Using cointegrated equations to study long run relationship between agricultural product and gross domestic product in Saudi Arabia Dirasat Agricultural Sciences 29(2): Ar153-Ar166
Hannah, H.W. 1989: Animal patents Journal of the American Veterinary Medical Association 195(5): 577-578
Gogstad, G. 1999: Going astray when it comes to gene patents Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 119(23): 3475-3476
Lundsteen, C. 2000: No to patents for genetic diagnostics Ugeskrift for Laeger 162(25): 3620-3621
Schena, F.P. 2003: Research and development. the value of patents Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 20(5): 447-449
Gallegos, A.J. 1982: Use and disuse of patents in Mexican biomedicine Gaceta Medica de Mexico 118(2): 45-48
Drake, P.M.W.; Thangaraj, H. 2010: Molecular farming, patents and access to medicines Expert Review of Vaccines 9(8): 811-819
Drake, P.M.W.; Thangaraj, H. 2010: Molecular farming, patents and access to medicines Expert Review of Vaccines 9(8): 811-819
Borrell, J. 2007: Pricing and patents of HIV/AIDS drugs in developing countries Applied Economics 39(4): 505-518
Cullet, P. 2003: Patents and medicines: the relationship between TRIPS and the human right to health International Affairs 79(1): 139-160
Borrell, J. 2005: Patents and the faster introduction of new drugs in developing countries Applied Economics Letters 12(6): 379-382
Goemaere, E.; Kaninda, A-Valerie.; Ciaffi, L.; Mulemba, M.; t Hoen, E.; Pécoul, B. 2002: Do patents prevent access to drugs for HIV in developing countries? JAMA 287(7): 841
Borrell, J. 2007: Pricing and patents of HIV/AIDS drugs in developing countries Applied Economics 39(4): 505-518
Boelaert, M.; Lynen, L.; Van Damme, W.; Colebunders, R. 2002: Do patents prevent access to drugs for HIV in developing countries? JAMA 287(7): 840
McCallum, L.; Faunce, T. 2015: Myriad Voices against Gene Patents in the high Court Journal of Law and Medicine 23(2): 322-329
Círman, Z. 1975: Protection of patents in pharmacy, chemistry and microbiology in Czechoslovakia Ceskoslovenska Farmacie 24(8): 344-350